logo

For the Inventor, By the Inventor

Leuven, Belgium

Victoria A Ploplis

This inventor holds 9 USPTO granted patents. Top assignee: American Biogenetic Sciences, Inc.. Active years: 1992-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victoria A Ploplis. Retrieved from https://idiyas.com/inventor/victoria-a-ploplis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 78(Granted Patents)


Location History:

  • Southbend, IN (US) (1992 - 1993)
  • Louvain, BE (1999)
  • Leuven, BE (1995 - 2001)

Company Filing History:

goldMedal9 out of 23 
 
American Biogenetic Sciences, Inc.
 patents

Years Active: 1992-2001

Loading Chart...
9 patents (USPTO):Explore Patents
1. 6294173 - Methods for treating a tumor containing fibrin using a fibrin specific monoclonal antibody and compositions used therein (2001-09-25),
2. 6187593 - Methods for treating a fibrin encapsulated tumor using a fibrin specific monoclonal antibody and compositions used therein (2001-02-13),
3. 5871737 - Methods for treating a fibrin encapsulated tumor using a fibrin specific (1999-02-16),
4. 5723126 - Methods and compositions for therapeutic uses of a fibrin-specific (1998-03-03),
5. 5721122 - Method comprising immunization of antigen-free mice (1998-02-24),
6. 5453359 - Immunoassay and kit for in vitro detection of soluble DesAABB fibrin (1995-09-26),
7. 5223410 - Method for production of antibodies utilizing an antigen-free animal (1993-06-29),
8. 5120834 - Fibrin-specific monoclonal antibody (1992-06-09),
9. 5091512 - Fibrinogen-specific monoclonal antibody (1992-02-25),

Title: Victoria A Ploplis: Innovator in Monoclonal Antibody Development

Introduction

Victoria A Ploplis is a distinguished inventor based in Leuven, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies for clinical applications. With a total of 9 patents to her name, her work has the potential to impact cancer treatment and diagnostics.

Latest Patents

Among her latest patents are innovative methods for treating tumors that contain fibrin using fibrin-specific monoclonal antibodies. One notable patent describes a method for producing these monoclonal antibodies utilizing an immunized germ-free animal. This invention not only provides a fibrin-specific monoclonal antibody but also outlines methods for its use in both in vitro and in vivo clinical diagnostics and therapeutics. Another patent focuses on treating fibrin-encapsulated tumors with similar methodologies, further emphasizing her expertise in this critical area of medical research.

Career Highlights

Victoria A Ploplis is currently associated with American Biogenetic Sciences, Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving therapeutic options for patients suffering from various conditions, particularly cancer.

Collaborations

She has collaborated with notable colleagues such as Paul E Gargan and Julian R Pleasants, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Victoria A Ploplis stands out as a leading figure in the field of monoclonal antibody research. Her innovative approaches and dedication to improving clinical outcomes highlight her significant role in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…